Nervous System Research, Novartis Pharma AG, 4002 Basel, Switzerland. fabrizio.gasparini@pharma.novartis.com
Abstract:
The synthesis of a new potent, subtype-selective radioligand [(3)H]-M-MPEP (2-methyl-6-((3-methoxyphenyl)ethynyl)-pyridine) and its in vitro pharmacological characteristics are described. Science Ltd.